News
Sixty seconds on . . . Twitter Blue
BMJ 2022; 379 doi: https://doi.org/10.1136/bmj.o2730 (Published 11 November 2022) Cite this as: BMJ 2022;379:o2730
- Mun-Keat Looi
- The BMJ
The Twitter blues—a new medical syndrome?
It might well be. But here we’re talking about one of the changes made to the popular social platform since billionaire Elon Musk took over. Causing the biggest stir are his changes to official verified status and its merging with the service’s subscription tier called Twitter Blue.
What’s that?
It’s a paid for premium service that adds various exclusive features, the most notable of which …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.